img

Global and India Monoclonal Antibody Drug Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and India Monoclonal Antibody Drug Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and India Monoclonal Antibody Drug Market
This report focuses on global and India Monoclonal Antibody Drug market, also covers the segmentation data of other regions in regional level and county level.
The global Monoclonal Antibody Drug revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the review period (2024-2034).
In India the Monoclonal Antibody Drug revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period 2024-2034.
The global key players of Monoclonal Antibody Drug include Abbott, Johnson & Johnson, Roche, Ono Pharmaceutical, Amgen, Merck, Jiangsu Hengrui Pharmaceuticals, Beigene and Shanghai Junshi Biosciences, etc. The global five biggest players hold a share of % in 2024.
Global Monoclonal Antibody Drug Scope and Market Size
Monoclonal Antibody Drug market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Monoclonal Antibody Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For India market, this report focuses on the Monoclonal Antibody Drug market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in India.



By Company


Abbott
Johnson & Johnson
Roche
Ono Pharmaceutical
Amgen
Merck
Jiangsu Hengrui Pharmaceuticals
Beigene
Shanghai Junshi Biosciences
Innovent Biologics
WuXi Biologics (Cayman)
Shanghai Henlius Biotech
Akeso
Lepu Biopharma
CStone Pharmaceuticals
Hillhouse Investment Management
Alphamab Oncology
Novartis
Takeda Pharmaceutical
Segment by Type
Humanized Monoclonal Antibody Drugs
Fully Human Monoclonal Antibody Drugs
Small Molecule Antibody Drugs
Chimeric Monoclonal Antibody Drugs
Other

Segment by Application


Cancer Treatment
Autoimmune Disease Treatment
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Monoclonal Antibody Drug definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Monoclonal Antibody Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Monoclonal Antibody Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Monoclonal Antibody Drug revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Monoclonal Antibody Drug Product Introduction
1.2 Global Monoclonal Antibody Drug Outlook 2018 VS 2024 VS 2034
1.2.1 Global Monoclonal Antibody Drug Market Size for the Year 2018-2034
1.2.2 India Monoclonal Antibody Drug Market Size for the Year 2018-2034
1.3 Monoclonal Antibody Drug Market Size, India VS Global, 2018 VS 2024 VS 2034
1.3.1 The Market Share of India Monoclonal Antibody Drug in Global, 2018 VS 2024 VS 2034
1.3.2 The Growth Rate of Monoclonal Antibody Drug Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4 Monoclonal Antibody Drug Market Dynamics
1.4.1 Monoclonal Antibody Drug Industry Trends
1.4.2 Monoclonal Antibody Drug Market Drivers
1.4.3 Monoclonal Antibody Drug Market Challenges
1.4.4 Monoclonal Antibody Drug Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Monoclonal Antibody Drug by Type
2.1 Monoclonal Antibody Drug Market Segment by Type
2.1.1 Humanized Monoclonal Antibody Drugs
2.1.2 Fully Human Monoclonal Antibody Drugs
2.1.3 Small Molecule Antibody Drugs
2.1.4 Chimeric Monoclonal Antibody Drugs
2.1.5 Other
2.2 Global Monoclonal Antibody Drug Market Size by Type (2018, 2024 & 2034)
2.3 Global Monoclonal Antibody Drug Market Size by Type (2018-2034)
2.4 India Monoclonal Antibody Drug Market Size by Type (2018, 2024 & 2034)
2.5 India Monoclonal Antibody Drug Market Size by Type (2018-2034)
3 Monoclonal Antibody Drug by Application
3.1 Monoclonal Antibody Drug Market Segment by Application
3.1.1 Cancer Treatment
3.1.2 Autoimmune Disease Treatment
3.2 Global Monoclonal Antibody Drug Market Size by Application (2018, 2024 & 2034)
3.3 Global Monoclonal Antibody Drug Market Size by Application (2018-2034)
3.4 India Monoclonal Antibody Drug Market Size by Application (2018, 2024 & 2034)
3.5 India Monoclonal Antibody Drug Market Size by Application (2018-2034)
4 Global Monoclonal Antibody Drug Competitor Landscape by Company
4.1 Global Monoclonal Antibody Drug Market Size by Company
4.1.1 Global Key Companies of Monoclonal Antibody Drug, Ranked by Revenue (2024)
4.1.2 Global Monoclonal Antibody Drug Revenue by Player (2018-2023)
4.2 Global Monoclonal Antibody Drug Concentration Ratio (CR)
4.2.1 Monoclonal Antibody Drug Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Monoclonal Antibody Drug in 2024
4.2.3 Global Monoclonal Antibody Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Monoclonal Antibody Drug Head office and Area Served
4.4 Global Key Players of Monoclonal Antibody Drug, Product and Application
4.5 Global Key Players of Monoclonal Antibody Drug, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Monoclonal Antibody Drug Market Size by Company
4.7.1 Key Players of Monoclonal Antibody Drug in India, Ranked by Revenue (2024)
4.7.2 India Monoclonal Antibody Drug Revenue by Players (2021, 2024 & 2023)
5 Global Monoclonal Antibody Drug Market Size by Region
5.1 Global Monoclonal Antibody Drug Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Monoclonal Antibody Drug Market Size by Region (2018-2034)
5.2.1 Global Monoclonal Antibody Drug Market Size by Region: 2018-2023
5.2.2 Global Monoclonal Antibody Drug Market Size by Region (2024-2034)
6 Americas
6.1 Americas Monoclonal Antibody Drug Market Size YoY Growth 2018-2034
6.2 Americas Monoclonal Antibody Drug Market Size by Type
6.2.1 Americas Monoclonal Antibody Drug Market Size by Type (2018-2023)
6.2.2 Americas Monoclonal Antibody Drug Market Size by Type (2024-2034)
6.2.3 Americas Monoclonal Antibody Drug Market Share by Type (2018-2034)
6.3 Americas Monoclonal Antibody Drug Market Size by Application
6.3.1 Americas Monoclonal Antibody Drug Market Size by Application (2018-2023)
6.3.2 Americas Monoclonal Antibody Drug Market Size by Application (2024-2034)
6.3.3 Americas Monoclonal Antibody Drug Market Share by Application (2018-2034)
6.4 Americas Monoclonal Antibody Drug Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Monoclonal Antibody Drug Market Size YoY Growth 2018-2034
7.2 EMEA Monoclonal Antibody Drug Market Size by Type
7.2.1 EMEA Monoclonal Antibody Drug Market Size by Type (2018-2023)
7.2.2 EMEA Monoclonal Antibody Drug Market Size by Type (2024-2034)
7.2.3 EMEA Monoclonal Antibody Drug Market Share by Type (2018-2034)
7.3 EMEA Monoclonal Antibody Drug Market Size by Application
7.3.1 EMEA Monoclonal Antibody Drug Market Size by Application (2018-2023)
7.3.2 EMEA Monoclonal Antibody Drug Market Size by Application (2024-2034)
7.3.3 EMEA Monoclonal Antibody Drug Market Share by Application (2018-2034)
7.4 EMEA Monoclonal Antibody Drug Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Monoclonal Antibody Drug Market Size YoY Growth 2018-2034
8.2 China Monoclonal Antibody Drug Market Size by Type
8.2.1 China Monoclonal Antibody Drug Market Size by Type (2018-2023)
8.2.2 China Monoclonal Antibody Drug Market Size by Type (2024-2034)
8.2.3 China Monoclonal Antibody Drug Market Share by Type (2018-2034)
8.3 China Monoclonal Antibody Drug Market Size by Application
8.3.1 China Monoclonal Antibody Drug Market Size by Application (2018-2023)
8.3.2 China Monoclonal Antibody Drug Market Size by Application (2024-2034)
8.3.3 China Monoclonal Antibody Drug Market Share by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Monoclonal Antibody Drug Market Size YoY Growth 2018-2034
9.2 APAC Monoclonal Antibody Drug Market Size by Type
9.2.1 APAC Monoclonal Antibody Drug Market Size by Type (2018-2023)
9.2.2 APAC Monoclonal Antibody Drug Market Size by Type (2024-2034)
9.2.3 APAC Monoclonal Antibody Drug Market Share by Type (2018-2034)
9.3 APAC Monoclonal Antibody Drug Market Size by Application
9.3.1 APAC Monoclonal Antibody Drug Market Size by Application (2018-2023)
9.3.2 APAC Monoclonal Antibody Drug Market Size by Application (2024-2034)
9.3.3 APAC Monoclonal Antibody Drug Market Share by Application (2018-2034)
9.4 APAC Monoclonal Antibody Drug Market Facts & Figures by Country (2018, 2024 & 2034)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Abbott
10.1.1 Abbott Company Details
10.1.2 Abbott Business Overview
10.1.3 Abbott Monoclonal Antibody Drug Introduction
10.1.4 Abbott Revenue in Monoclonal Antibody Drug Business (2018-2023)
10.1.5 Abbott Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Details
10.2.2 Johnson & Johnson Business Overview
10.2.3 Johnson & Johnson Monoclonal Antibody Drug Introduction
10.2.4 Johnson & Johnson Revenue in Monoclonal Antibody Drug Business (2018-2023)
10.2.5 Johnson & Johnson Recent Development
10.3 Roche
10.3.1 Roche Company Details
10.3.2 Roche Business Overview
10.3.3 Roche Monoclonal Antibody Drug Introduction
10.3.4 Roche Revenue in Monoclonal Antibody Drug Business (2018-2023)
10.3.5 Roche Recent Development
10.4 Ono Pharmaceutical
10.4.1 Ono Pharmaceutical Company Details
10.4.2 Ono Pharmaceutical Business Overview
10.4.3 Ono Pharmaceutical Monoclonal Antibody Drug Introduction
10.4.4 Ono Pharmaceutical Revenue in Monoclonal Antibody Drug Business (2018-2023)
10.4.5 Ono Pharmaceutical Recent Development
10.5 Amgen
10.5.1 Amgen Company Details
10.5.2 Amgen Business Overview
10.5.3 Amgen Monoclonal Antibody Drug Introduction
10.5.4 Amgen Revenue in Monoclonal Antibody Drug Business (2018-2023)
10.5.5 Amgen Recent Development
10.6 Merck
10.6.1 Merck Company Details
10.6.2 Merck Business Overview
10.6.3 Merck Monoclonal Antibody Drug Introduction
10.6.4 Merck Revenue in Monoclonal Antibody Drug Business (2018-2023)
10.6.5 Merck Recent Development
10.7 Jiangsu Hengrui Pharmaceuticals
10.7.1 Jiangsu Hengrui Pharmaceuticals Company Details
10.7.2 Jiangsu Hengrui Pharmaceuticals Business Overview
10.7.3 Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Introduction
10.7.4 Jiangsu Hengrui Pharmaceuticals Revenue in Monoclonal Antibody Drug Business (2018-2023)
10.7.5 Jiangsu Hengrui Pharmaceuticals Recent Development
10.8 Beigene
10.8.1 Beigene Company Details
10.8.2 Beigene Business Overview
10.8.3 Beigene Monoclonal Antibody Drug Introduction
10.8.4 Beigene Revenue in Monoclonal Antibody Drug Business (2018-2023)
10.8.5 Beigene Recent Development
10.9 Shanghai Junshi Biosciences
10.9.1 Shanghai Junshi Biosciences Company Details
10.9.2 Shanghai Junshi Biosciences Business Overview
10.9.3 Shanghai Junshi Biosciences Monoclonal Antibody Drug Introduction
10.9.4 Shanghai Junshi Biosciences Revenue in Monoclonal Antibody Drug Business (2018-2023)
10.9.5 Shanghai Junshi Biosciences Recent Development
10.10 Innovent Biologics
10.10.1 Innovent Biologics Company Details
10.10.2 Innovent Biologics Business Overview
10.10.3 Innovent Biologics Monoclonal Antibody Drug Introduction
10.10.4 Innovent Biologics Revenue in Monoclonal Antibody Drug Business (2018-2023)
10.10.5 Innovent Biologics Recent Development
10.11 WuXi Biologics (Cayman)
10.11.1 WuXi Biologics (Cayman) Company Details
10.11.2 WuXi Biologics (Cayman) Business Overview
10.11.3 WuXi Biologics (Cayman) Monoclonal Antibody Drug Introduction
10.11.4 WuXi Biologics (Cayman) Revenue in Monoclonal Antibody Drug Business (2018-2023)
10.11.5 WuXi Biologics (Cayman) Recent Development
10.12 Shanghai Henlius Biotech
10.12.1 Shanghai Henlius Biotech Company Details
10.12.2 Shanghai Henlius Biotech Business Overview
10.12.3 Shanghai Henlius Biotech Monoclonal Antibody Drug Introduction
10.12.4 Shanghai Henlius Biotech Revenue in Monoclonal Antibody Drug Business (2018-2023)
10.12.5 Shanghai Henlius Biotech Recent Development
10.13 Akeso
10.13.1 Akeso Company Details
10.13.2 Akeso Business Overview
10.13.3 Akeso Monoclonal Antibody Drug Introduction
10.13.4 Akeso Revenue in Monoclonal Antibody Drug Business (2018-2023)
10.13.5 Akeso Recent Development
10.14 Lepu Biopharma
10.14.1 Lepu Biopharma Company Details
10.14.2 Lepu Biopharma Business Overview
10.14.3 Lepu Biopharma Monoclonal Antibody Drug Introduction
10.14.4 Lepu Biopharma Revenue in Monoclonal Antibody Drug Business (2018-2023)
10.14.5 Lepu Biopharma Recent Development
10.15 CStone Pharmaceuticals
10.15.1 CStone Pharmaceuticals Company Details
10.15.2 CStone Pharmaceuticals Business Overview
10.15.3 CStone Pharmaceuticals Monoclonal Antibody Drug Introduction
10.15.4 CStone Pharmaceuticals Revenue in Monoclonal Antibody Drug Business (2018-2023)
10.15.5 CStone Pharmaceuticals Recent Development
10.16 Hillhouse Investment Management
10.16.1 Hillhouse Investment Management Company Details
10.16.2 Hillhouse Investment Management Business Overview
10.16.3 Hillhouse Investment Management Monoclonal Antibody Drug Introduction
10.16.4 Hillhouse Investment Management Revenue in Monoclonal Antibody Drug Business (2018-2023)
10.16.5 Hillhouse Investment Management Recent Development
10.17 Alphamab Oncology
10.17.1 Alphamab Oncology Company Details
10.17.2 Alphamab Oncology Business Overview
10.17.3 Alphamab Oncology Monoclonal Antibody Drug Introduction
10.17.4 Alphamab Oncology Revenue in Monoclonal Antibody Drug Business (2018-2023)
10.17.5 Alphamab Oncology Recent Development
10.18 Novartis
10.18.1 Novartis Company Details
10.18.2 Novartis Business Overview
10.18.3 Novartis Monoclonal Antibody Drug Introduction
10.18.4 Novartis Revenue in Monoclonal Antibody Drug Business (2018-2023)
10.18.5 Novartis Recent Development
10.19 Takeda Pharmaceutical
10.19.1 Takeda Pharmaceutical Company Details
10.19.2 Takeda Pharmaceutical Business Overview
10.19.3 Takeda Pharmaceutical Monoclonal Antibody Drug Introduction
10.19.4 Takeda Pharmaceutical Revenue in Monoclonal Antibody Drug Business (2018-2023)
10.19.5 Takeda Pharmaceutical Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Monoclonal Antibody Drug Market Size India VS Global, CAGR (2018 VS 2024 VS 2034)
Table 2. Monoclonal Antibody Drug Market Trends
Table 3. Monoclonal Antibody Drug Market Drivers
Table 4. Monoclonal Antibody Drug Market Challenges
Table 5. Monoclonal Antibody Drug Market Restraints
Table 6. Global Monoclonal Antibody Drug Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India Monoclonal Antibody Drug Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Monoclonal Antibody Drug Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India Monoclonal Antibody Drug Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Companies of Monoclonal Antibody Drug, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Monoclonal Antibody Drug Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Monoclonal Antibody Drug Revenue Share by Player, 2018-2023
Table 13. Global Monoclonal Antibody Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Monoclonal Antibody Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Drug as of 2024)
Table 15. Global Key Players of Monoclonal Antibody Drug, Headquarters and Area Served
Table 16. Global Key Players of Monoclonal Antibody Drug, Product and Application
Table 17. Global Key Players of Monoclonal Antibody Drug, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Monoclonal Antibody Drug in India, Ranked by Revenue (2024) & (US$ Million)
Table 20. India Monoclonal Antibody Drug Revenue by Players, (US$ Million), 2021, 2024 & 2023
Table 21. India Monoclonal Antibody Drug Revenue Share by Players, 2021, 2024 & 2023
Table 22. Global Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 23. Global Monoclonal Antibody Drug Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Monoclonal Antibody Drug Market Size Forecast by Region (2024-2034) & (US$ Million)
Table 25. Americas Monoclonal Antibody Drug Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Monoclonal Antibody Drug Market Size by Type (2024-2034) & (US$ Million)
Table 27. Americas Monoclonal Antibody Drug Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Monoclonal Antibody Drug Market Size by Application (2024-2034) & (US$ Million)
Table 29. Americas Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 30. Americas Monoclonal Antibody Drug Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Monoclonal Antibody Drug Market Size by Country (2024-2034) & (US$ Million)
Table 32. EMEA Monoclonal Antibody Drug Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Monoclonal Antibody Drug Market Size by Type (2024-2034) & (US$ Million)
Table 34. EMEA Monoclonal Antibody Drug Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Monoclonal Antibody Drug Market Size by Application (2024-2034) & (US$ Million)
Table 36. EMEA Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. EMEA Monoclonal Antibody Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Monoclonal Antibody Drug Market Size by Country (2024-2034) & (US$ Million)
Table 39. China Monoclonal Antibody Drug Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Monoclonal Antibody Drug Market Size by Type (2024-2034) & (US$ Million)
Table 41. China Monoclonal Antibody Drug Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Monoclonal Antibody Drug Market Size by Application (2024-2034) & (US$ Million)
Table 43. China Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. APAC Monoclonal Antibody Drug Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Monoclonal Antibody Drug Market Size by Type (2024-2034) & (US$ Million)
Table 46. APAC Monoclonal Antibody Drug Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Monoclonal Antibody Drug Market Size by Application (2024-2034) & (US$ Million)
Table 48. APAC Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 49. APAC Monoclonal Antibody Drug Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Monoclonal Antibody Drug Market Size by Region (2024-2034) & (US$ Million)
Table 51. Abbott Company Details
Table 52. Abbott Business Overview
Table 53. Abbott Monoclonal Antibody Drug Product
Table 54. Abbott Revenue in Monoclonal Antibody Drug Business (2018-2023) & (US$ Million)
Table 55. Abbott Recent Development
Table 56. Johnson & Johnson Company Details
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson Monoclonal Antibody Drug Product
Table 59. Johnson & Johnson Revenue in Monoclonal Antibody Drug Business (2018-2023) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. Roche Company Details
Table 62. Roche Business Overview
Table 63. Roche Monoclonal Antibody Drug Product
Table 64. Roche Revenue in Monoclonal Antibody Drug Business (2018-2023) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Ono Pharmaceutical Company Details
Table 67. Ono Pharmaceutical Business Overview
Table 68. Ono Pharmaceutical Monoclonal Antibody Drug Product
Table 69. Ono Pharmaceutical Revenue in Monoclonal Antibody Drug Business (2018-2023) & (US$ Million)
Table 70. Ono Pharmaceutical Recent Development
Table 71. Amgen Company Details
Table 72. Amgen Business Overview
Table 73. Amgen Monoclonal Antibody Drug Product
Table 74. Amgen Revenue in Monoclonal Antibody Drug Business (2018-2023) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Monoclonal Antibody Drug Product
Table 79. Merck Revenue in Monoclonal Antibody Drug Business (2018-2023) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Jiangsu Hengrui Pharmaceuticals Company Details
Table 82. Jiangsu Hengrui Pharmaceuticals Business Overview
Table 83. Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Product
Table 84. Jiangsu Hengrui Pharmaceuticals Revenue in Monoclonal Antibody Drug Business (2018-2023) & (US$ Million)
Table 85. Jiangsu Hengrui Pharmaceuticals Recent Development
Table 86. Beigene Company Details
Table 87. Beigene Business Overview
Table 88. Beigene Monoclonal Antibody Drug Product
Table 89. Beigene Revenue in Monoclonal Antibody Drug Business (2018-2023) & (US$ Million)
Table 90. Beigene Recent Development
Table 91. Shanghai Junshi Biosciences Company Details
Table 92. Shanghai Junshi Biosciences Business Overview
Table 93. Shanghai Junshi Biosciences Monoclonal Antibody Drug Product
Table 94. Shanghai Junshi Biosciences Revenue in Monoclonal Antibody Drug Business (2018-2023) & (US$ Million)
Table 95. Shanghai Junshi Biosciences Recent Development
Table 96. Innovent Biologics Company Details
Table 97. Innovent Biologics Business Overview
Table 98. Innovent Biologics Monoclonal Antibody Drug Product
Table 99. Innovent Biologics Revenue in Monoclonal Antibody Drug Business (2018-2023) & (US$ Million)
Table 100. Innovent Biologics Recent Development
Table 101. WuXi Biologics (Cayman) Company Details
Table 102. WuXi Biologics (Cayman) Business Overview
Table 103. WuXi Biologics (Cayman) Monoclonal Antibody Drug Product
Table 104. WuXi Biologics (Cayman) Revenue in Monoclonal Antibody Drug Business (2018-2023) & (US$ Million)
Table 105. WuXi Biologics (Cayman) Recent Development
Table 106. Shanghai Henlius Biotech Company Details
Table 107. Shanghai Henlius Biotech Business Overview
Table 108. Shanghai Henlius Biotech Monoclonal Antibody Drug Product
Table 109. Shanghai Henlius Biotech Revenue in Monoclonal Antibody Drug Business (2018-2023) & (US$ Million)
Table 110. Shanghai Henlius Biotech Recent Development
Table 111. Akeso Company Details
Table 112. Akeso Business Overview
Table 113. Akeso Monoclonal Antibody Drug Product
Table 114. Akeso Revenue in Monoclonal Antibody Drug Business (2018-2023) & (US$ Million)
Table 115. Akeso Recent Development
Table 116. Lepu Biopharma Company Details
Table 117. Lepu Biopharma Business Overview
Table 118. Lepu Biopharma Monoclonal Antibody Drug Product
Table 119. Lepu Biopharma Revenue in Monoclonal Antibody Drug Business (2018-2023) & (US$ Million)
Table 120. Lepu Biopharma Recent Development
Table 121. CStone Pharmaceuticals Company Details
Table 122. CStone Pharmaceuticals Business Overview
Table 123. CStone Pharmaceuticals Monoclonal Antibody Drug Product
Table 124. CStone Pharmaceuticals Revenue in Monoclonal Antibody Drug Business (2018-2023) & (US$ Million)
Table 125. CStone Pharmaceuticals Recent Development
Table 126. Hillhouse Investment Management Company Details
Table 127. Hillhouse Investment Management Business Overview
Table 128. Hillhouse Investment Management Monoclonal Antibody Drug Product
Table 129. Hillhouse Investment Management Revenue in Monoclonal Antibody Drug Business (2018-2023) & (US$ Million)
Table 130. Hillhouse Investment Management Recent Development
Table 131. Alphamab Oncology Company Details
Table 132. Alphamab Oncology Business Overview
Table 133. Alphamab Oncology Monoclonal Antibody Drug Product
Table 134. Alphamab Oncology Revenue in Monoclonal Antibody Drug Business (2018-2023) & (US$ Million)
Table 135. Alphamab Oncology Recent Development
Table 136. Novartis Company Details
Table 137. Novartis Business Overview
Table 138. Novartis Monoclonal Antibody Drug Product
Table 139. Novartis Revenue in Monoclonal Antibody Drug Business (2018-2023) & (US$ Million)
Table 140. Novartis Recent Development
Table 141. Takeda Pharmaceutical Company Details
Table 142. Takeda Pharmaceutical Business Overview
Table 143. Takeda Pharmaceutical Monoclonal Antibody Drug Product
Table 144. Takeda Pharmaceutical Revenue in Monoclonal Antibody Drug Business (2018-2023) & (US$ Million)
Table 145. Takeda Pharmaceutical Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Monoclonal Antibody Drug Product Picture
Figure 2. Global Monoclonal Antibody Drug Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Monoclonal Antibody Drug Market Size 2018-2034 (US$ Million)
Figure 4. India Monoclonal Antibody Drug Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 5. India Monoclonal Antibody Drug Market Size 2018-2034 (US$ Million)
Figure 6. India Monoclonal Antibody Drug Market Share in Global 2018-2034
Figure 7. Monoclonal Antibody Drug Report Years Considered
Figure 8. Product Picture of Humanized Monoclonal Antibody Drugs
Figure 9. Product Picture of Fully Human Monoclonal Antibody Drugs
Figure 10. Product Picture of Small Molecule Antibody Drugs
Figure 11. Product Picture of Chimeric Monoclonal Antibody Drugs
Figure 12. Product Picture of Other
Figure 13. Global Monoclonal Antibody Drug Market Share by Type in 2024 & 2034
Figure 14. Global Monoclonal Antibody Drug Market Size by Type (2018-2034) & (US$ Million)
Figure 15. Global Monoclonal Antibody Drug Market Share by Type (2018-2034)
Figure 16. India Monoclonal Antibody Drug Market Share by Type in 2024 & 2034
Figure 17. India Monoclonal Antibody Drug Market Size by Type (2018-2034) & (US$ Million)
Figure 18. India Monoclonal Antibody Drug Market Share by Type (2018-2034)
Figure 19. Product Picture of Cancer Treatment
Figure 20. Product Picture of Autoimmune Disease Treatment
Figure 21. Global Monoclonal Antibody Drug Market Share by Application in 2024 & 2034
Figure 22. Global Monoclonal Antibody Drug Market Size by Application (2018-2034) & (US$ Million)
Figure 23. Global Monoclonal Antibody Drug Market Share by Application (2018-2034)
Figure 24. India Monoclonal Antibody Drug Market Share by Application in 2024 & 2034
Figure 25. India Monoclonal Antibody Drug Market Size by Application (2018-2034) & (US$ Million)
Figure 26. India Monoclonal Antibody Drug Market Share by Application (2018-2034)
Figure 27. The Top 5 and 10 Largest Companies of Monoclonal Antibody Drug in the World: Market Share by Monoclonal Antibody Drug Revenue in 2024
Figure 28. Global Monoclonal Antibody Drug Market Size Market Share by Region: 2018 VS 2024 VS 2034
Figure 29. Global Monoclonal Antibody Drug Market Share by Region (2018-2034)
Figure 30. Americas Monoclonal Antibody Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 31. Americas Monoclonal Antibody Drug Market Share by Type (2018-2034)
Figure 32. Americas Monoclonal Antibody Drug Market Share by Application (2018-2034)
Figure 33. United States Monoclonal Antibody Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 34. Canada Monoclonal Antibody Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 35. Mexico Monoclonal Antibody Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 36. Brazil Monoclonal Antibody Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 37. EMEA Monoclonal Antibody Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 38. EMEA Monoclonal Antibody Drug Market Share by Type (2018-2034)
Figure 39. EMEA Monoclonal Antibody Drug Market Share by Application (2018-2034)
Figure 40. Europe Monoclonal Antibody Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 41. Middle East Monoclonal Antibody Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 42. Africa Monoclonal Antibody Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 43. China Monoclonal Antibody Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 44. China Monoclonal Antibody Drug Market Share by Type (2018-2034)
Figure 45. China Monoclonal Antibody Drug Market Share by Application (2018-2034)
Figure 46. APAC Monoclonal Antibody Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 47. APAC Monoclonal Antibody Drug Market Share by Type (2018-2034)
Figure 48. APAC Monoclonal Antibody Drug Market Share by Application (2018-2034)
Figure 49. Japan Monoclonal Antibody Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 50. South Korea Monoclonal Antibody Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 51. China Taiwan Monoclonal Antibody Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 52. Southeast Asia Monoclonal Antibody Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 53. India Monoclonal Antibody Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 54. Abbott Revenue Growth Rate in Monoclonal Antibody Drug Business (2018-2023)
Figure 55. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibody Drug Business (2018-2023)
Figure 56. Roche Revenue Growth Rate in Monoclonal Antibody Drug Business (2018-2023)
Figure 57. Ono Pharmaceutical Revenue Growth Rate in Monoclonal Antibody Drug Business (2018-2023)
Figure 58. Amgen Revenue Growth Rate in Monoclonal Antibody Drug Business (2018-2023)
Figure 59. Merck Revenue Growth Rate in Monoclonal Antibody Drug Business (2018-2023)
Figure 60. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Monoclonal Antibody Drug Business (2018-2023)
Figure 61. Beigene Revenue Growth Rate in Monoclonal Antibody Drug Business (2018-2023)
Figure 62. Shanghai Junshi Biosciences Revenue Growth Rate in Monoclonal Antibody Drug Business (2018-2023)
Figure 63. Innovent Biologics Revenue Growth Rate in Monoclonal Antibody Drug Business (2018-2023)
Figure 64. WuXi Biologics (Cayman) Revenue Growth Rate in Monoclonal Antibody Drug Business (2018-2023)
Figure 65. Shanghai Henlius Biotech Revenue Growth Rate in Monoclonal Antibody Drug Business (2018-2023)
Figure 66. Akeso Revenue Growth Rate in Monoclonal Antibody Drug Business (2018-2023)
Figure 67. Lepu Biopharma Revenue Growth Rate in Monoclonal Antibody Drug Business (2018-2023)
Figure 68. CStone Pharmaceuticals Revenue Growth Rate in Monoclonal Antibody Drug Business (2018-2023)
Figure 69. Hillhouse Investment Management Revenue Growth Rate in Monoclonal Antibody Drug Business (2018-2023)
Figure 70. Alphamab Oncology Revenue Growth Rate in Monoclonal Antibody Drug Business (2018-2023)
Figure 71. Novartis Revenue Growth Rate in Monoclonal Antibody Drug Business (2018-2023)
Figure 72. Takeda Pharmaceutical Revenue Growth Rate in Monoclonal Antibody Drug Business (2018-2023)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries